{
    "Trade/Device Name(s)": [
        "Xpert MRSA NxG Assay",
        "Xpert MRSA NxG"
    ],
    "Submitter Information": "Cepheid",
    "510(k) Number": "K162444",
    "Predicate Device Reference 510(k) Number(s)": [
        "K133605"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NQX",
        "OOI"
    ],
    "Summary Letter Date": "August 30, 2016",
    "Summary Letter Received Date": "August 31, 2016",
    "Submission Date": "November 8, 2016",
    "Regulation Number(s)": [
        "21 CFR 866.1640",
        "21 CFR 862.2570"
    ],
    "Regulation Name(s)": [
        "Antimicrobial test powder",
        "Instrumentation for clinical multiplex test systems"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Methicillin-resistant Staphylococcus aureus (MRSA) DNA",
        "mecA gene",
        "mecC gene",
        "SCCmec (staphylococcal cassette chromosome mec)"
    ],
    "Specimen Type(s)": [
        "Nasal swab"
    ],
    "Specimen Container(s)": [
        "Cepheid Sample Collection Device",
        "Copan Liquid Amies Elution Swab (ESwab) collection and transport system"
    ],
    "Instrument(s)/Platform(s)": [
        "Cepheid GeneXpert Instrument Systems",
        "GeneXpert Dx",
        "GeneXpert Infinity-48",
        "GeneXpert Infinity-48s",
        "GeneXpert Infinity-80"
    ],
    "Method(s)/Technology(ies)": [
        "Real-time polymerase chain reaction (PCR)",
        "Automated sample preparation",
        "Fluorogenic target-specific hybridization probes"
    ],
    "Methodologies": [
        "Qualitative nucleic acid amplification",
        "Multiplex real-time PCR"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent",
        "Cartridge"
    ],
    "Document Summary": "FDA 510(k) summary for Cepheid Xpert MRSA NxG real-time PCR assay for direct qualitative detection of MRSA DNA from nasal swabs using GeneXpert platform",
    "Indications for Use Summary": "Qualitative in vitro diagnostic test for detection of MRSA DNA directly from nasal swabs in patients at risk for nasal colonization, performed on GeneXpert Instrument Systems to aid in prevention and control of MRSA infections in healthcare settings; not intended for diagnosis, guidance, or monitoring of MRSA treatment",
    "fda_folder": "Microbiology"
}